Serum β‐Synuclein as a Potential Early Biomarker for Alzheimer's Disease
Our findings indicate that serum β-synuclein is a promising biomarker for early AD. Its association with disease progression and minimally invasive nature highlight its potential for early detection and monitoring.
Authors
- Jianping Jia
- Yumei Liang
- Siqi Xie
- the Alzheimer's Disease Neuroimaging Initiative
Institutions
- Ministry of Education of the People's Republic of China (CN)
- Capital Medical University (CN)
- Beijing Geriatric Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Chinese Institute for Brain Research (CN)
- National Clinical Research (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101498
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00